Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
about
A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokineticsImpaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiencyApplications of CYP450 testing in the clinical settingPharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for cliniciansClinical use of pharmacogenomic tests in 2009Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugsGenotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patientsPharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.Pharmacogenetics of healthy volunteers in Puerto RicoPolymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancersCytochrome P450 2B diversity and dietary novelty in the herbivorous, desert woodrat (Neotoma lepida)Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision MedicineEffects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitroContribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK-PD modelling analysisFunctional evaluation of genetic and environmental regulators of p450 mRNA levelsInfluence of the CYP2D6 isoenzyme in patients treated with venlafaxine for major depressive disorder: clinical and economic consequencesHuman genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease.Mining SNPs from EST databases.Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Cytochrome P450-2D6 Genotype Definition May Improve Therapy for Paroxysmal Atrial Fibrillation A Case of Syncope Following "Pill-in-the-Pocket" Quinidine plus Propafenone.Pharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancerThe association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patientsCytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.Pharmacogenetics of antidepressant response.Inferring haplotypes of copy number variations from high-throughput data with uncertaintyPopulation pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects.Recent advances in the use of opioids for cancer painReduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer.Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African AmericansCYP2D6 inhibition and breast cancer recurrence in a population-based study in Denmark.CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess.Genetic influences on smoking: candidate genes.Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.Copy number variants in pharmacogenetic genes.3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.The contributions of normal variation and genetic background to mammalian gene expression.Addressing phenoconversion: the Achilles' heel of personalized medicine.CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.
P2860
Q24602122-D05BC23A-15AD-4D51-AA81-0CC47B10C60EQ24609157-30792B19-AD5C-4E1F-A451-187CB555BEF3Q24621760-514D575E-074B-45BD-984C-C8DC8615134AQ24657338-5B2FE22C-7029-4F3D-8F17-DC13F450DB92Q24657536-16312A3D-C411-4DA3-985F-B680E7B7D3B5Q24683013-BE036046-76C7-43B6-B10B-257D309AE873Q24810279-83351BB9-006D-4D00-BBB3-87AE1A83A9A4Q24812002-83D04844-6A4C-45F3-8E4C-B005C1BAE3BAQ26779038-0F4CF2AE-0CDF-41E7-878E-FD0596E7C3A7Q27010137-CA6832D7-0F2E-4058-8FC5-236D7466168DQ27331784-C8344FB3-8407-49C2-853B-72B394923F7AQ27692687-8A260029-CCD4-4B56-9F36-121FC43CB232Q28295439-9894827A-8A02-41CD-A431-382B6BA686EFQ28343852-F88609D6-05CF-4AB0-8A9D-D3B8DDB79409Q28477350-6B3ECA0B-2518-4B58-874A-A36587FAF790Q28544689-2774A108-6FB5-4345-B452-BFF77E34B965Q30479569-3FD05E34-531B-4390-940E-BAF93847760DQ30634765-25CF087B-3CD1-41E6-B065-A30EFF405003Q31144283-7959214B-E2D6-4B6A-9251-0D3063B6740CQ33168000-91CD7DF5-28C3-4FDB-8E08-36B822DABC6BQ33597438-2914B0AF-C655-4F99-8D84-127088B8DDE9Q33608783-87D79C6C-3AD0-4D47-B1AF-64380197E4CAQ33641660-580FEDC6-C480-4E80-B3A3-EE65EA562F0CQ34132390-23C38D64-131A-42C2-96A4-88FC2A998731Q34155796-BCDC5BC5-6A3A-4210-BFB3-1B7026539289Q34182841-6090EABA-C36F-485D-A4A5-FE8CDE9D68C6Q34209573-D16F3DAF-5610-4795-B45E-1E995AD8B38CQ34387297-21AD2241-9A49-4C19-845E-F0724E2448B1Q34418203-8F28237A-AC6B-47E0-9B9D-DF30C22FC60BQ34498728-7EE01A20-8B15-44FE-96AA-716D905B1E24Q34546846-D7BDA240-1602-40F1-9F6F-0B335C25B601Q34677193-FD700301-6904-4D63-93FD-AD255D45BF1CQ34794075-D7A4B822-F3A6-4CB7-81CC-F55E1A0E34A7Q34938233-3B3DBBB1-E193-443A-BDBB-C532A71DE40DQ34939015-3B7322BD-8012-4AD8-A251-403837424FEBQ34975631-4173EC14-9D2C-40CD-A0E5-B62AD0441C07Q35004902-D83F2A8E-1949-4C99-9943-F85C41F74642Q35012903-77E793FB-8E8F-4EAA-A1C1-8951C453C37AQ35023701-D0B1C9ED-13DA-444A-9690-96F74B077056Q35078387-2DB07865-ED7C-4592-9709-406510D63983
P2860
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@ast
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@en
type
label
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@ast
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@en
prefLabel
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@ast
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@en
P2093
P2860
P1476
Cytochrome P450 2D6 variants i ...... s and phenotypic consequences.
@en
P2093
P2860
P304
P407
P577
1997-02-01T00:00:00Z